Zimbabwe has launched lenacapavir, an HIV prevention drug administered biannually, aiming to curb infections. While offering ...

Bulawayo has marked a major milestone in Zimbabwe's fight against HIV following the launch of Lenacapavir, a long-acting injectable pre-exposure prophylaxis ...

Tanzania has officially registered Lenacapavir, a long-acting injectable drug for the prevention and control of HIV, marking what officials describe as a significant milestone in the ...

Zimbabwe is one of the world's first countries to roll out lenacapavir, a long-acting HIV prevention drug that is ...

HARARE: Young women, mothers holding babies and some men lined up in a dusty field on the outskirts of Zimbabwe's capital, Harare. They came for injections of a ...

In the global fight against HIV, the "holy grail" has long been the quest for a prevention method that is highly effective, discreet, and easy to maintain.

President Donald Trump wants to strip public health funding from four states led by Democratic leaders—including $8 million from Illinois.

With clinical studies demonstrating near-total protection, lenacapavir has been described by some health officials as a ...

South Africa will launch Lenacapavir, a six-month HIV prevention injection, in six provinces, targeting all HIV-negative individuals to curb new infections.

Background A more nuanced understanding of behavioural responses to incentives over time, particularly after they are removed, could guide more effective interventions. In this study, we build on the ...